StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.52+0.57 (+1.90%)

Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%

Pfizer U.S. Commercial Division Revenues [legacy 2024–2025 by Quarter

U.S. Commercial Division Revenues [legacy 2024–2025 structure] ($M) ($M)

Pfizer U.S. Commercial Division Revenues [legacy 2024–2025: $9,031M in Q4 2025, down 0.9% from a year earlier.

Latest, Q4 2025
9,031
Period ended Dec 31, 2025
Change on a year earlier
-0.9%
9,114 in Q4 2024
History
12 quarters
Since Q1 2023
Sources
7
Documents cited below

Where the Q4 2025 figure comes from

Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)

Source: Form 10-K (filed 2026-02-26) ↗

Reported in Form 10-K Note 17 Segment & Geographic Information.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedU.S. Commercial Division Revenues [legacy 2024–2025 structure] ($M) ($M)Year on yearSource
Q4 2025Dec 31, 20259,031-0.9%Form 10-K (filed 2026-02-26) ↗
Q3 2025Sep 28, 202510,599-11.4%Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 29, 20258,793+12.3%Form 10-Q (filed 2025-08-05) ↗
Q1 2025Mar 30, 20258,285-12.1%Form 10-Q (filed 2025-05-05) ↗
Q4 2024Dec 31, 20249,114-17.7%Form 10-K (filed 2026-02-26) ↗
Q3 2024Sep 29, 202411,964+104.0%Form 10-Q (filed 2025-11-04) ↗
Q2 2024Jun 30, 20247,828+86.4%Form 10-Q (filed 2025-08-05) ↗
Q1 2024Mar 31, 20249,426+42.5%Form 10-Q (filed 2025-05-05) ↗
Q4 2023Dec 31, 202311,070–Form 10-K (filed 2026-02-26) ↗
Q3 2023Oct 1, 20235,864–Form 10-Q (filed 2024-11-04) ↗
Q2 2023Jul 2, 20234,200–Form 10-Q (filed 2024-08-05) ↗
Q1 2023Apr 2, 20236,615–Form 10-Q (filed 2024-05-08) ↗

Breakdown

What makes up U.S. Commercial Division Revenues [legacy 2024–2025

Cite this data

StockData. (2026). Pfizer U.S. Commercial Division Revenues [legacy 2024–2025 ($M), quarterly Q1 2023–Q4 2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/div-leg-us-comm

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.